Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Molecular Cancer

Molecular Cancer

Molecular Cancer

Editors-in-Chief: Christophe Nicot

ISSN: 1476-4598 (electronic version)

Journal no. 12943

BioMed Central

Open access BioMed Central
 Learn more about the metrics of this journal
  • High visibility - receives over 70,000 articles accesses a month
  • Ranked in the top 25% in the Oncology category of Journal Citation Reports
  • Welcomes articles in both molecular and clinical aspects of cancer research

As an internationally recognized journal, Molecular Cancer is dedicated to the innovation of how basic cancer research drives advances in cancer prevention, diagnostics, and treatment. Ranked in the top 25% in the Oncology category of Journal Citation Reports, the journal receives over 70,000 article accesses a month. The journal prides itself on less than 7 days time-to-first-decision, welcoming submissions of broad interest including: target therapies; molecular and cellular biology; genomics; genetics and epigenetics; pathology and tumor immunology. Molecular Cancer is the definitive journal for researchers and clinicians in the field of molecular oncology.   

Related subjects » Cancer Research - Oncology & Hematology

Impact Factor: 7.776 (2017) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, BIOSIS, CNKI, Current Abstracts, Current Contents, DOAJ, EBSCO Academic Search, EBSCO Biomedical Reference Collection, EBSCO Discovery Service, EBSCO STM Source, EBSCO TOC Premier, Health Reference Center Academic, OCLC WorldCat Discovery Service, Pathway Studio, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

Read This journal on BioMed Central

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 7.776
  • Aims and Scope

    Aims and Scope


    Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

    Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.

    Molecular Cancer provides an important forum for exciting findings in cancer-related research, presenting an unparalleled opportunity to communicate information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.

  • Submit Online
  • English Language Editing

    English Language Editing


  • Writing Resources: Training for Authors